Three Phase III Randomized Controlled Trials of Topical Resiquimod 0.01-Percent Gel to Reduce Anogenital Herpes Recurrences

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00077-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials With Time‐to‐Event Outcomes

Oncologist
Cancer ResearchMedicineOncology
2019English

Randomized Controlled Trials

Phlebology
MedicineCardiovascular MedicineCardiology
2011English

Randomized Controlled Trials

JAMA - Journal of the American Medical Association
Medicine
2005English

Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Systematic Review and Meta-Analyses of Randomized Controlled Trials

Dermatology and Therapy
Dermatology
2019English

How Should a Clinician Interpret Results of Randomized Controlled Trials?: Interpretation of Randomized Controlled Trials

Acta medica Lituanica
2010English

Antivirals for Management of Herpes Zoster Including Ophthalmicus: A Systematic Review of High-Quality Randomized Controlled Trials

Antiviral Therapy
Infectious DiseasesPharmacology
2011English

Pragmatic Design in Randomized Controlled Trials

Psychological Medicine
PsychiatryMental HealthApplied Psychology
2014English

Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail the Last Barrier?

International Journal of Cancer
Cancer ResearchOncology
2018English

Moving Forward With Randomized Controlled Trials

Research in gerontological nursing
Health PolicyGerontologyGeriatricsNursing
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy